Lower Costs, More Paperwork: New Barriers to Prescription Drugs
Chart of the Day: Medicare, Medicaid, and Insurers Replaced High Costs With More Hurdles, LDI Expert Finds
Optimizing insurance and access to health care to provide high-quality health care.
Chart of the Day: Medicare, Medicaid, and Insurers Replaced High Costs With More Hurdles, LDI Expert Finds
Chart of the Day: Mark Cuban’s Cost Plus Drugs Can Save Employer-Covered Patients Hundreds on Some Generics
Will Implementation Create Sweeping Losses or a Return to Balance and Self-Sufficiency?
An LDI Fellow and Chronic Pain Researcher Call on Health Plans To Lower Barriers to Physical Therapy, Acupuncture, and Interdisciplinary Pain Care
Chart of the Day: Researchers Urge Easier Renewals and Better Support To Prevent Gaps in Care
While They Wait for Medicare, People Approved for Social Security Disability Die at Higher Rates Compared to the General Public
Two Pediatricians Share Key Dates and Practical Next Steps
Medicare’s Payment Plan Can Ease Seniors’ Crushing Drug Costs but Medicare Buries it in the Fine Print
Even With Lower Prices, Medicare, Medicaid, and Other Insurers Tighten Coverage for Drugs Like Mounjaro and Zepbound Using Prior Authorization and Other Tools
This working group bring together Penn investigators to build Penn’s capacity to provide high-quality, evidence-based analyses that contribute to the improvement of population health in the United States.